Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Clinical trial NCT03562208 · UNKNOWN

Trial details

NCT number: NCT03562208
Sponsor: Global Cell Med
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Progression Diabetes Complications

Start date: 2018-01-01
Primary completion: 2020-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.